Risk Of Recurrence After Withdrawal Of Anticoagulation In Patients With Unprovoked Venous Thromboembolism: External Validation Of The Vienna Nomogram And The Dash Prediction Score

被引:6
|
作者
Marin-Romero, Samira [1 ]
Elias-Hernandez, Teresa [1 ]
Isabel Asensio-Cruz, Maria [1 ]
Ortega-Rivera, Rocio [1 ]
Morillo-Guerrero, Raquel [2 ]
Toral, Javier [3 ]
Montero, Emilio [3 ]
Sanchez, Veronica [4 ]
Arellano, Elena [4 ]
Sanchez-Diaz, Jose Maria [1 ]
Real-Dominguez, Macarena [5 ]
Otero-Candelera, Remedios [1 ]
Jara-Palomares, Luis [1 ,6 ]
机构
[1] Hosp Univ Virgen Rocio, Unidad Med Quirurg Enfermedades Resp, Seville, Spain
[2] Hosp Ramon & Cajal, Serv Neumol, Madrid, Spain
[3] Hosp Univ Virgen Rocio, Unidad Urgencias & Emergencias, Seville, Spain
[4] Univ Seville, Hosp Univ Virgen Rocio, CSIC, Inst Biomed Sevilla IBiS, Seville, Spain
[5] Univ Malaga, Dept Med Prevent & Salud Publ, Malaga, Spain
[6] Inst Salud Carlos III, CIBERES, Madrid, Spain
来源
ARCHIVOS DE BRONCONEUMOLOGIA | 2019年 / 55卷 / 12期
关键词
Decision support techniques; Venous thromboembolism; Validation studies (Publication type); Pulmonary embolism; Venous thrombosis; ACUTE PULMONARY-EMBOLISM; ANTITHROMBOTIC THERAPY; DIAGNOSIS; THROMBOSIS; DURATION; RATES; RULE; COHORT; MODEL;
D O I
10.1016/j.arbres.2019.03.025
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Scales for predicting venous thromboembolism (VTE) recurrence are useful for deciding the duration of the anticoagulant treatment. Although there are several scales, the most appropriate for our setting has not been identified. For this reason, we aimed to validate the DASH prediction score and the Vienna nomogram at 12 months. Methods: This was a retrospective study of unselected consecutive VTE patients seen between 2006 and 2014. We compared the ability of the DASH score and the Vienna nomogram to predict recurrences of VTE. The validation was performed by stratifying patients as low-risk or high-risk, according to each scale (discrimination) and comparing the observed recurrence with the expected rate (calibration). Results: Of 353 patients evaluated, 195 were analyzed, with an average age of 53.5 +/- 19 years. There were 21 recurrences in 1 year (10.8%, 95% CI: 6.8%-16%). According to the DASH score, 42% were classified as low risk, and the rate of VTE recurrence in this group was 4.9% (95% CI: 1.3%-12%) vs. the high-risk group that was 15% (95% CI: 9%-23%) (p < .05). According to the Vienna nomogram, 30% were classified as low risk, and the rate of VTE recurrence in the low risk group vs. the high risk group was 4.2% (95% CI:0.5%-14%) vs. 16.2% (95% CI: 9.9%-24.4%) (p < .05). Conclusions: Our study validates the DASH score and the Vienna nomogram in our population. The DASH prediction score may be the most advisable, both because of its simplicity and its ability to identify more low-risk patients than the Vienna nomogram (42% vs. 30%). (C) 2019 SEPAR. Published by Elsevier Espana. S.L.U. All rights reserved.
引用
收藏
页码:619 / 626
页数:8
相关论文
共 50 条
  • [31] External validation of the SAVED score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulatory drugs
    Dima, Danai
    Li, Ang
    Granat, Lauren M.
    Dhillon, Puneet
    Chamseddine, Fatima
    Yalamanchali, Anirudh
    Mirzai, Saeid
    Wei, Wei
    Samaras, Christy J.
    Valent, Jason
    Anwer, Faiz
    Khouri, Jack
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (02) : 280 - 284
  • [32] Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism The Vienna Prediction Model
    Eichinger, Sabine
    Heinze, Georg
    Jandeck, Lisanne M.
    Kyrle, Paul A.
    CIRCULATION, 2010, 121 (14) : 1630 - 1636
  • [33] Effectiveness and safety of oral anticoagulation treatment beyond 1 year after venous thromboembolism in patients at intermediate recurrence risk
    Johnsen, Soren P.
    Rasmussen, Thomas B.
    Falstie-Jensen, Anne Mette
    Harboe, Louise
    Stynes, Gillian
    Dybro, Lars
    Hansen, Morten L.
    Brandes, Axel
    Grove, Erik L.
    Munster, Anna-Marie
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2021, 129 (03) : 210 - 220
  • [34] External validation of the VTE-BLEED score for predicting major bleeding in stable anticoagulated patients with venous thromboembolism
    Klok, Frederikus A.
    Barco, Stefano
    Konstantinides, Stavros V.
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (06) : 1164 - 1170
  • [35] Validation of the clinical prediction rule for recurrent venous thromboembolism in cancer patients: the Ottawa score
    Ahn, Shin
    Lim, Kyung Soo
    Lee, Yoon-Seon
    Lee, Jae-Lyun
    SUPPORTIVE CARE IN CANCER, 2013, 21 (08) : 2309 - 2313
  • [36] Validation of the clinical prediction rule for recurrent venous thromboembolism in cancer patients: the Ottawa score
    Shin Ahn
    Kyung Soo Lim
    Yoon-Seon Lee
    Jae-Lyun Lee
    Supportive Care in Cancer, 2013, 21 : 2309 - 2313
  • [37] Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Hepatocellular Carcinoma
    Wang, Y.
    Attar, B. M.
    Fuentes, H. E.
    Yu, J.
    Zhang, Huiyuan
    Tafur, A. J.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (03) : 471 - 476
  • [38] Association between remote major venous thromboembolism risk factors and the risk of recurrence after a first unprovoked episode
    Farren-Dai, L.
    Carrier, M.
    Kovacs, J.
    Rodger, M.
    Kovacs, M. J.
    Le Gal, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (10) : 1977 - 1980
  • [39] A nomogram model to predict the acute venous thromboembolism risk after surgery in patients with glioma
    Zhang, Chuanhao
    Deng, Zhenghai
    Yang, Zuocheng
    Xie, Jian
    Hou, Zonggang
    THROMBOSIS RESEARCH, 2023, 224 : 21 - 31
  • [40] A nomogram model to predict the venous thromboembolism risk after surgery in patients with gynecological tumors
    Wang, Li
    Wei, Shanchen
    Zhou, Bohui
    Wu, Suhui
    THROMBOSIS RESEARCH, 2021, 202 : 52 - 58